Two main cellular components in rheumatoid arthritis: Communication between T cells and fibroblast-like synoviocytes in the joint synovium

J Tu, W Huang, W Zhang, J Mei, C Zhu - Frontiers in immunology, 2022 - frontiersin.org
Rheumatoid arthritis (RA) is a chronic autoimmune disease that endangers the health of
approximately 1% of the global population. Current RA medications on the market mainly …

Effect of T cells on bone

K Okamoto, H Takayanagi - Bone, 2023 - Elsevier
Bone and immune systems mutually influence each other by sharing a variety of regulatory
molecules and the tissue microenvironment. The interdisciplinary research field …

Antcin K inhibits TNF-α, IL-1β and IL-8 expression in synovial fibroblasts and ameliorates cartilage degradation: implications for the treatment of rheumatoid arthritis

D Achudhan, SC Liu, YY Lin, CC Huang… - Frontiers in …, 2021 - frontiersin.org
Extracts from Taiwan's traditional medicinal mushroom, Antrodia cinnamomea, exhibit anti-
inflammatory activities in cellular and preclinical studies. However, this paper is the first to …

Prediction of targets of curculigoside A in osteoporosis and rheumatoid arthritis using network pharmacology and experimental verification

J Han, M Wan, Z Ma, C Hu, H Yi - Drug Design, Development and …, 2020 - Taylor & Francis
Purpose Network pharmacology is considered to be the next-generation drug development
model that uses bioinformatics to predict and identify multiple drug targets and interactions …

Th1-related transcription factors and cytokines in systemic lupus erythematosus

YY Tang, DC Wang, YY Chen, WD Xu… - Frontiers in …, 2023 - frontiersin.org
Systemic lupus erythematosus (SLE) is an inflammatory disorder related to immunity
dysfunction. The Th1 cell family including Th1 cells, transcription factor T-bet, and related …

Modulating inflammation through the neutralization of Interleukin-6 and tumor necrosis factor-α by biofunctionalized nanoparticles

AC Lima, D Amorim, I Laranjeira, A Almeida… - Journal of Controlled …, 2021 - Elsevier
Biological agents that neutralize the activity of pro-inflammatory cytokines are revolutionizing
the treatment of inflammatory conditions. However, the antibodies (Abs) short half-life and off …

Discovery and preclinical evaluation of KYS202004A, a novel bispecific fusion protein targeting TNF-α and IL-17A, in autoimmune disease models

Z Liu, L Song, J Yang, H Liu, Y Zhang, X Pi… - International …, 2024 - Elsevier
The treatment of autoimmune and inflammatory diseases often requires targeting multiple
pathogenic pathways. KYS202004A is a novel bispecific fusion protein designed to …

[HTML][HTML] Targeting fusion proteins of the interleukin family: A promising new strategy for the treatment of autoinflammatory diseases

Y Zhao, H Wang, L Jin, Z Zhang, L Liu, M Zhou… - European Journal of …, 2024 - Elsevier
As a means of communication between immune cells and non-immune cells, Interleukins
(ILs) has the main functions of stimulating the proliferation and activation of inflammatory …

[HTML][HTML] Ameliorative effects of a fusion protein dual targeting interleukin 17A and tumor necrosis factor α on imiquimod-induced psoriasis in mice

Z Liu, H Liu, P Xu, Q Yin, Y Wang, YK Opoku… - Biomedicine & …, 2018 - Elsevier
In recent decades, biological agents such as tumor necrosis factor-α (TNF-α) inhibitors, have
revolutionized the treatment of psoriasis. However, inhibition of a single cytokine may not …

Addition of a viral immunomodulatory domain to etanercept generates a bifunctional chemokine and TNF inhibitor

A Alejo, C Sánchez, S Amu, PG Fallon… - Journal of Clinical …, 2019 - mdpi.com
The inhibition of tumor necrosis factor (TNF) through the use of either antibodies or soluble
receptors is a highly effective strategy for the clinical control of chronic inflammatory …